Sai Life Sciences Limited
BlackRock decreased its stake in Sai Life Sciences from 1.30% to 1.12%, selling 366,946 shares. The value of the sold shares is ₹52.19 Cr at a price of ₹1422.20 per share.
A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
World's largest asset manager, headquartered in New York. Manages USD 14 trillion globally. India FPI exposure spans active funds, iShares ETFs and emerging market strategies.